Kintor Pharmaceutical Ltd KNTPF:OTCPK

RT Quote | Exchange | USD
Last | 12/11/20 EST
1.23UNCH (UNCH)
52 week range
1.23 - 1.23

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.23
  • 52 Week High1.23
  • 52 Week High Date12/11/20
  • 52 Week Low1.23
  • 52 Week Low Date12/11/20
  • Market Cap803.92M
  • Shares Out369.39M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.17
  • P/E (TTM)-7.26
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Kintor Pharmaceutical Ltd News

There is no recent news for this security.

Latest KNTPF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China. The Company is focused on the research and development of drugs for cancers and other androgen receptor (AR) related diseases. Its primary drug candidate is Proxalutamide which is in phase III clinical trials in China for metastatic castration-resistant prostate cancer (mCRPC). The Company are also developing other drug candidates, including a phase II small molecule drug candidate Pyrilutamide, a...
Tong Youzhi
Chairman
Lu Yan
Chief Financial Officer
Yan Mingming
Vice President
Address
Suzhou, JNG
China